Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
QEL-001 by Quell Therapeutics for Liver Transplant Rejection: Likelihood of Approval
QEL-001 is under clinical development by Quell Therapeutics and currently in Phase II for Liver Transplant Rejection. According to GlobalData,...